MYWOT
Child safety
Confidence
Trustworthiness
Confidence
MALICIOUS CONTENT INDICATORS
Nascentbiotech.com most likely does not offer any malicious content.
Secure connection support
HTTPS
Nascentbiotech.com provides SSL-encrypted connection.
ADULT CONTENT INDICATORS
Nascentbiotech.com most likely does not offer any adult content.
Popular pages
-
Investor Relations - Nascent Biotech
Investor Relations Nascent Biotech is building a portfolio of innovative therapeutic antibodies, poised at various stages of development, ranging from laboratory to the eve of preclinical trials. Nasc...
-
Nascent Biotech Opens Phase 1 Human Trial to Evaluate Pritumumab as Treatment Option for Primary and
SAN DIEGO, CA / ACCESSWIRE / March 24, 2021 / Nascent Biotech, Inc. (OTCQB:NBIO) (“Nascent Biotech”, “Nascent”, or the “Company”), a clinical-stage biotechnology Company pioneering the development of ...
-
Nascent Begins Enrollment of Final Patient Cohort to Complete Phase One Clinical Research - Nascent
VERO BEACH, FL / ACCESSWIRE / October 4, 2022 / Nascent Biotech, Inc. (OTCQB:NBIO) (“Nascent Biotech”, “Nascent”, or the “Company”), a clinical-stage biotechnology Company focused on the development o...
-
Nascent Successfully Completes 2nd Cohort Dosing in Key Phase 1 Metastatic Brain Cancer Trial
VERO BEACH, FL / ACCESSWIRE / January 11, 2022 / Nascent Biotech, Inc. (OTCQB:NBIO) (“Nascent Biotech”, “Nascent”, or the “Company”), a clinical-stage biotechnology Company pioneering the development ...
-
Nascent Biotech News - Nascent Biotech
Nascent Biotech News © NASCENT BIOTECH, INC. ALL RIGHTS RESERVED.
-
Nascent Submits Phase 2 Clinical Research Protocol to FDA for Review and Approval - Nascent Biotech
NORTH PALM BEACH, FL / ACCESSWIRE / April 18, 2023 / Nascent Biotech, Inc. (OTCQB:NBIO) (“Nascent Biotech”, “Nascent”, or the “Company”), a clinical-stage biotechnology Company whose business is focus...